Year: 2024
Type: dissertation
Abstract: Stroke is one of the leading causes of death and disability worldwide. Current therapies focus on reducing the impact of the ischemic insult and there are no strategies to promote repair of the injured brain. Harnessing the potential of stem cells to treat injury or disease has been at the forefront of regenerative medicine. Neural stem cell-based strategies to treat the stroke injured brain include exogenous stem cell transplantation and endogenous neural precursor cell (NPC) activation. Herein, we explored the potential for a novel source of human neural precursor cells, cortically specified neuroepithelial progenitors (cNEPs), to enhance functional recovery in a preclinical endothelin-1 mouse model of stroke. We transplanted cNEPs during the acute phase post-stroke which represents a clinically relevant treatment paradigm. Transplanted cNEPs improved functional stroke outcomes without generating mature neurons and long-term survival of the transplanted cells was not necessary to maintain improved function. We next sought to understand the potential of a novel apoptosis inhibitor to reduce cell death and enhance endogenous NPC survival following stroke. We found that delivery of a caspase 3/7 inhibitor, NWL283, during the first week post-stroke was sufficient to increase neuronal survival in the injured parenchyma and increase the numbers of NPCs in the neurogenic subventricular zone post-stroke. The endogenous NPCs migrated to the stroke injury site in greater numbers in mice that received NWL283, which coincided with improved functional outcomes. Again, we found that NPC differentiation into mature neurons was not necessary for the improved outcomes. Finally, we explored the translational potential of our approach using a human organoid model to test whether human NPCs were responsive to NWL283. We first identified two distinct populations of human neural stem cells (primitive and definitive neural stem cells), that were identified and characterized in the murine forebrain. When exposed to NWL28, we found less cell death in the developing human organoids however, the size of the neural stem cell pool was not expanded. Together, these studies highlight the potential for stem cell-based strategies to improve stroke outcomes and reveal that NPC differentiation into mature neurons is not necessary for long-term functional benefits.
Source: TSpace (University of Toronto)
Author: Islam, Rehnuma
Institution: University of Toronto
Language: English
Subfield: Developmental Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7133078033
